Danaher Corporation is rated Buy with a target price of $250, implying 10.5% upside from $226.25. DHR's strong Q3 execution featured 4.5% revenue growth, margin expansion to 37.2%, and robust free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback